Cerus Corporation (CERS)

Cerus Corporation (CERS) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $459M; returns 1 day +0.9%, 1 week +6.9%, 1 year +54.3%.

Cerus Corporation (NASDAQ: CERS) is a biomedical products company based in Concord, California, dedicated to safeguarding the world's blood supply. Founded in 1991, Cerus develops and commercializes the INTERCEPT Blood System, a technology designed to inactivate pathogens in donated blood components, thereby reducing the risk of transfusion-transmitted infections.

Groups CERS belongs to

• Healthcare
• Biotechnology
• Medical Devices
• Healthcare Equipment
• Life Sciences
• B2B Software
• Commercial Stage
• Public Safety and Security
• Infectious Diseases

CERS financial model: income statement, cash flow and balance sheet